Nvidia Pours $50M into AI Drug Discovery Pioneer, Recursion

Discover the exciting partnership as Nvidia invests a staggering $50 million into the pioneering AI drug discovery company, Recursion. In this episode, we delve into the implications of this collaboration, exploring how it's poised to revolutionize the pharmaceutical industry. Join us for an in-depth discussion on the intersection of AI and life-saving innovation.

Get on the AI Box Waitlist: https://AIBox.ai/
Join our ChatGPT Community: ⁠https://www.facebook.com/groups/739308654562189/⁠
Follow me on Twitter: ⁠https://twitter.com/jaeden_ai⁠

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.